MH3D

BALTIMORE, MD – November, 2025 – MH3D is proud to officially announce the first commercial installation of its flagship preclinical SPECT/CT imaging system, the Alpha-SPECT™ Mini. The state-of-the-art system has been installed at the prestigious Johns Hopkins University School of Medicine. The Alpha-SPECT™ Mini represents a significant leap forward in preclinical imaging technology. It is the only preclinical SPECT imaging scanner on the market utilizing CZT (Cadmium Zinc Telluride)...

Ann Arbor, MI – October 6, 2025 – MH3D Inc. is proud to announce that it has been awarded the Commercial Innovation Award of the Year at the World Molecular Imaging Congress (WMIC) 2025. This award recognizes MH3D’s groundbreaking work in advancing high-resolution, CZT-based SPECT imaging solutions designed to accelerate theranostics and radioligand therapy research. The honor underscores the impact of MH3D’s technology on the global molecular imaging community, providing researchers with...

Ann Arbor, MI — July 2025 — There is a growing demand from medical research institutions for high resolution, compact imaging tools to...